Elisa Ferretti

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors.

Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors.

Journal: Frontiers in immunology
Published: February 17, 2025

Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors Surveillance.

Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors Surveillance.

Journal: Cancers
Published: November 11, 2020

Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.

Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.

Journal: Cancer immunology research
Published: April 20, 2020

miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy.

miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy.

Journal: Frontiers in cell and developmental biology
Published: November 30, 2019

Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models.

Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: November 06, 2019

Harnessing NK Cells for Cancer Treatment.

Harnessing NK Cells for Cancer Treatment.

Journal: Frontiers in immunology
Published: August 14, 2019

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.

Journal: Cancers
Published: February 06, 2019

IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Journal: Oncoimmunology
Published: July 27, 2017

The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment.

The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment.

Journal: Journal of leukocyte biology
Published: January 24, 2017

Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.

Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.

Journal: Oncotarget
Published: December 20, 2016

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma.

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma.

Journal: Oncoimmunology
Published: December 13, 2016

Editorial: Targeting JAM-C on mantle cell lymphoma B cells: time for clinical testing?

Editorial: Targeting JAM-C on mantle cell lymphoma B cells: time for clinical testing?

Journal: Journal of leukocyte biology
Published: June 01, 2016
Showing 1-12 of 19

Last Updated: 09/26/2026